ConductScience.org, home

Paper40824641

Biannual Mass Azithromycin Distributions for Preschool Children and Malaria Parasitemia: A Secondary Analysis of the MORDOR Cluster Randomized Trial.

Arzika AM and 16 others. JAMA Netw Open, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Biannual Mass Azithromycin Distributions for Preschool Children and Malaria Parasitemia: A Secondary Analysis of the MORDOR Cluster Randomized Trial. Papers, record 40824641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40824641

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Biannual Mass Azithromycin Distributions for Preschool Children and Malaria Parasitemia: A Secondary Analysis of the MORDOR Cluster Randomized Trial.
PubMed
Journal
JAMA Netw Open
PubMed
Year
2025
PubMed
Publication types
Clinical Trial, Phase IV, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-07-17
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Arzika AMAhmed M
2Abdou AAmza
3Maliki RRamatou
4Lebas EElodie
5Cook CCatherine
6Vanderschelden BBenjamin
7O'Brien KSKieran S
8Cotter SYSun Y
9Varnado NENicole E
10Callahan EKE Kelly
11Bailey RLRobin L
12West SKSheila K
13Rosenthal PJPhilip J
14Porco TCTravis C
15Lietman TMThomas M
16Keenan JDJeremy D
17MORDOR-Niger Study GroupGroup

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
AntimalarialsMajor topic
AzithromycinMajor topic
MalariaMajor topic
Mass Drug AdministrationMajor topic
ParasitemiaMajor topic
Child, Preschool
Female
Humans
Infant
Male
Niger

Source PubMed

Download CSV of topics

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT02048007Mortality Reduction After Oral Azithromycin: Morbidity StudyDerived from the trialYesClinicalTrials.gov
NCT07712263Integrating the Guardian Spatial Emanator Within AVENIR IIBackgroundClinicalTrials.gov

Download CSV of trials

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122336792Intermittent preventive treatment for malaria in children living in areas with seasonal transmission.Cochrane Database Syst Rev2012https://conductscience.org/library/papers/22336792PubMed
230699301Effect of Adding Azithromycin to Seasonal Malaria Chemoprevention.N Engl J Med2019https://conductscience.org/library/papers/30699301PubMed
325223942Optimal seasonal timing of oral azithromycin for malaria.Am J Trop Med Hyg2014https://conductscience.org/library/papers/25223942PubMed
438816383Plasmodium falciparum infection in humans and mosquitoes influence natural Anopheline biting behavior and transmission.Nat Commun2024https://conductscience.org/library/papers/38816383PubMed
529694816Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa.N Engl J Med2018https://conductscience.org/library/papers/29694816PubMed
615838784A multicenter study of azithromycin, alone and in combination with chloroquine, for the treatment of acute uncomplicated Plasmodium falciparum malaria in India.J Infect Dis2005https://conductscience.org/library/papers/15838784PubMed
710571428Impact of community-based mass treatment for trachoma with oral azithromycin on general morbidity in Gambian children.Pediatr Infect Dis J1999https://conductscience.org/library/papers/10571428PubMed
835337289Malaria positivity following a single oral dose of azithromycin among children in Burkina Faso: a randomized controlled trial.BMC Infect Dis2022https://conductscience.org/library/papers/35337289PubMed
931167050Longer-Term Assessment of Azithromycin for Reducing Childhood Mortality in Africa.N Engl J Med2019https://conductscience.org/library/papers/31167050PubMed
107564674Effects of azithromycin on malariometric indices in The Gambia.Lancet1995https://conductscience.org/library/papers/7564674PubMed
1131237871Biannual mass azithromycin distributions and malaria parasitemia in pre-school children in Niger: A cluster-randomized, placebo-controlled trial.PLoS Med2019https://conductscience.org/library/papers/31237871PubMed
1212693587A comparative clinical trial of combinations of dihydroartemisinin plus azithromycin and dihydroartemisinin plus mefloquine for treatment of multidrug resistant falciparum malaria.Southeast Asian J Trop Med Public Health2002https://conductscience.org/library/papers/12693587PubMed
1329615044Simulation models predict that school-age children are responsible for most human-to-mosquito Plasmodium falciparum transmission in southern Malawi.Malar J2018https://conductscience.org/library/papers/29615044PubMed
1421976574Association of mass treatment with azithromycin in trachoma-endemic communities with short-term reduced risk of diarrhea in young children.Am J Trop Med Hyg2011https://conductscience.org/library/papers/21976574PubMed
1531796025Biannual versus annual mass azithromycin distribution and malaria seroepidemiology among preschool children in Niger: a sub-study of a cluster randomized trial.Malar J2019https://conductscience.org/library/papers/31796025PubMed
1630608051Mass Azithromycin Distribution to Prevent Childhood Mortality: A Pooled Analysis of Cluster-Randomized Trials.Am J Trop Med Hyg2019https://conductscience.org/library/papers/30608051PubMed
1729088030Annual Versus Biannual Mass Azithromycin Distribution and Malaria Parasitemia During the Peak Transmission Season Among Children in Niger.Pediatr Infect Dis J2018https://conductscience.org/library/papers/29088030PubMed
1819724043Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial.JAMA2009https://conductscience.org/library/papers/19724043PubMed
1934465327Effect of a single dose of oral azithromycin on malaria parasitaemia in children: a randomized controlled trial.Malar J2021https://conductscience.org/library/papers/34465327PubMed
2027215294In Vivo Efficacy and Tolerability of Artesunate-Azithromycin for the Treatment of Falciparum Malaria in Vietnam.Am J Trop Med Hyg2016https://conductscience.org/library/papers/27215294PubMed

See all 31 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42623398A single dose of azithromycin versus placebo for malaria in infants: A cluster-randomized trial.PLOS Glob Public Health2026https://conductscience.org/library/papers/42623398

Source PubMed

Download CSV of cited by

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
AZITHROMYCINCHEMBL529Derived from the trial1https://conductscience.org/library/drugs/CHEMBL529

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40824641

GET https://conductscience.org/api/papers/v1/40824641/references?page=2